Ocumetics Receives Ethics Committee Approval for First-In-Human Clinical Study of Accommodating Intraocular Lens

Core Insights - Ocumetics Technology Corp. has received verbal approval from the ethics committee for its first in-human study of the Ocumetics accommodating intraocular lens, with formal written approval expected by August 5, 2025 [1][2] Group 1: Clinical Study Approval - The ethics committee's approval is a significant milestone in Ocumetics' 18-year journey to innovate vision care, allowing the company to proceed with the first clinical use of the Ocumetics Lens [2] - The approved clinical study protocol includes clinical procedures, safety monitoring, inclusion and exclusion criteria, and study endpoints, ensuring compliance with international standards for patient safety and scientific integrity [2] Group 2: Collaboration and Development - The study will be conducted in collaboration with a recognized regulatory consulting group that contributed to the protocol development and submission to regulatory agencies [3] - The approval reflects the strength of the study protocol and the readiness of the clinical team, marking a major advancement in intraocular lens development [4] Group 3: Product Overview - Ocumetics has developed an innovative intraocular lens designed to fit within the natural lens compartment of the eye, potentially eliminating the need for corrective lenses [5] - The lens allows the eye's natural muscle activity to shift focus from distance to near, providing clear vision at all distances without glasses or contact lenses [5]